SCHEMBL30152015

SCHEMBL30152015

Cc1nc(Cl)cc(Nc2ncc(C(=O)Nc3c(CF)csc3Cl)s2)n1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIK2 Q9H0K1 11/20 0.57
SIK3 Q9Y2K2 11/20 0.57
SIK1 P57059 9/20 0.57
ABL1 P00519 11/20 0.55
LCK P06239 8/20 0.53
SRC P12931 6/20 0.53
KIT P10721 4/20 0.53
EGFR P00533 3/20 0.53
FYN P06241 3/20 0.53
YES1 P07947 3/20 0.53
LYN P07948 3/20 0.53
HCK P08631 3/20 0.53
BCR P11274 3/20 0.53
MAPK14 Q16539 3/20 0.53
MAPK13 O15264 2/20 0.53
ERBB2 P04626 2/20 0.53
FGR P09769 2/20 0.53
JAK3 P52333 2/20 0.53
MAPK12 P53778 2/20 0.53
MAPK11 Q15759 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23927244 1.00 SIK2 (0.57) SIK2SIK3SIK1ABL1LCK
SCHEMBL21875021 0.88 SIK2 (0.71) SIK2SIK3SIK1ABL1LCK
SCHEMBL23927248 0.86 SIK2 (0.58) SIK2SIK3SIK1ABL1LCK
SCHEMBL30152036 0.85 SIK2 (0.57) SIK2SIK3SIK1ABL1LCK
SCHEMBL23927264 0.85 SIK2 (0.57) SIK2SIK3SIK1ABL1LCK
SCHEMBL23927241 0.85 SIK2 (0.81) SIK2SIK3SIK1ABL1LCK
SCHEMBL30152001 0.85 SIK2 (0.81) SIK2SIK3SIK1ABL1LCK
SCHEMBL23927239 0.82 SIK2 (0.76) SIK2SIK3SIK1ABL1LCK
SCHEMBL23927235 0.82 SIK2 (0.84) SIK2SIK3SIK1ABL1LCK
SCHEMBL30151989 0.82 SIK2 (0.84) SIK2SIK3SIK1ABL1LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118369321-A Synthetic schemes and procedures for preparing SIK3 inhibitors and intermediates thereof 艾奥麦克斯治疗公司 2024-07-19 CN disclosed
EP-4139305-A1 HALOGENATED-HETEROARYL AND OTHER HETEROCYCLIC KINASE INHIBITORS, AND USES THEREOF iOmx Therapeutics AG (DE) 2023-03-01 EP disclosed
CN-115667255-A Halogenated heteroaryl and other heterocyclic kinase inhibitors and uses thereof 艾欧麦克斯治疗股份公司 2023-01-31 CN disclosed